Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Index
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - TScan Therapeutics (NASDAQ: TCRX)
Follow
NASDAQ:TCRX
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director
04/19/2024
Buy
$0.0001
8.85M
$885
43.16M
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director
04/19/2024
Buy
$0.0001
825,968
$83
4.02M
NASDAQ
TCRX
TScan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
04/19/2024
Buy
$0.0001
5.00M
$500
5.00M
NASDAQ
TCRX
TScan Therapeutics
Amello Jason
/
officer: Chief Financial Officer
02/01/2024
Buy
$5.15
750,000
$3.863M
750,000
NASDAQ
TCRX
TScan Therapeutics
BARBERICH TIMOTHY J
/
director
12/19/2023
Buy
$4.97
317
$2K
67,027
NASDAQ
TCRX
TScan Therapeutics
BARBERICH TIMOTHY J
/
director
12/18/2023
Buy
$4.89
28,830
$141K
66,710
NASDAQ
TCRX
TScan Therapeutics
Klencke Barbara
/
director
12/14/2023
Buy
$5.08
5,000
$25K
30,000
NASDAQ
TCRX
TScan Therapeutics
Woods Keith
/
director
12/06/2023
Buy
$6.74
17,500
$118K
17,500
NASDAQ
TCRX
TScan Therapeutics
Dworak Leiden
/
officer: Chief Accounting Officer
07/21/2023
Buy
$2.23
25,000
$56K
25,000
NASDAQ
TCRX
TScan Therapeutics
Dworak Leiden
/
officer: Chief Accounting Officer
07/21/2023
Sell
$2.90
37,500
$109K
0
NASDAQ
TCRX
TScan Therapeutics
Dworak Leiden
/
officer: Chief Accounting Officer
07/21/2023
Sell
$1.81
28,750
$52K
0
NASDAQ
TCRX
TScan Therapeutics
Dworak Leiden
/
officer: Chief Accounting Officer
07/21/2023
Sell
$2.49
163,800
$408K
0
NASDAQ
TCRX
TScan Therapeutics
BARBERICH TIMOTHY J
/
director
06/13/2023
Buy
$2.66
35,000
$93K
35,000
NASDAQ
TCRX
TScan Therapeutics
Barton Debora
/
officer: Chief Medical Officer
06/13/2023
Buy
$2.49
430,000
$1.071M
430,000
NASDAQ
TCRX
TScan Therapeutics
Dorton Katina
/
director
06/13/2023
Buy
$2.66
35,000
$93K
35,000
NASDAQ
TCRX
TScan Therapeutics
Gruia Gabriela
/
director
06/13/2023
Buy
$2.66
35,000
$93K
35,000
NASDAQ
TCRX
TScan Therapeutics
Klencke Barbara
/
director
06/13/2023
Buy
$2.66
36,524
$97K
36,524
NASDAQ
TCRX
TScan Therapeutics
Silver Brian M.
/
officer: Chief Financial Officer
06/13/2023
Buy
$2.49
632,500
$1.575M
632,500
NASDAQ
TCRX
TScan Therapeutics
MacBeath Gavin
/
director, officer: Chief Executive Officer
06/13/2023
Buy
$2.49
1.12M
$2.792M
1.12M
NASDAQ
TCRX
TScan Therapeutics
ZDRAVESKI ZORAN
/
officer: Chief Legal Officer
06/13/2023
Buy
$2.49
430,000
$1.071M
430,000
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director
06/13/2023
Buy
$2.66
35,000
$93K
35,000
NASDAQ
TCRX
TScan Therapeutics
BARBERICH TIMOTHY J
/
director
06/02/2023
Buy
$2.63
37,880
$100K
37,880
NASDAQ
TCRX
TScan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
05/31/2023
Sell
$2.51
10,000
$25K
5.24M
NASDAQ
TCRX
TScan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
05/31/2023
Sell
$2.52
15,000
$38K
5.23M
NASDAQ
TCRX
TScan Therapeutics
Lynx1 Capital Management LP
/
10 percent owner
05/31/2023
Sell
$2.51
400
$1K
5.22M
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director
06/01/2023
Buy
$0.0001
34.31M
$3K
34.31M
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director
06/01/2023
Buy
$0.0001
3.19M
$319
3.19M
NASDAQ
TCRX
TScan Therapeutics
Klencke Barbara
/
director
04/06/2023
Buy
$2.20
9,146
$20K
9,146
NASDAQ
TCRX
TScan Therapeutics
SOUTHWELL DAVID P
/
director, officer: Chief Executive Officer
02/02/2023
Buy
$1.81
100,000
$181K
100,000
NASDAQ
TCRX
TScan Therapeutics
MacBeath Gavin
/
officer: See Remarks
02/02/2023
Buy
$1.81
40,000
$72K
40,000
NASDAQ
TCRX
TScan Therapeutics
ZDRAVESKI ZORAN
/
officer: Chief Legal Officer
02/02/2023
Buy
$1.81
35,000
$63K
35,000
NASDAQ
TCRX
TScan Therapeutics
Barton Debora
/
officer: Chief Medical Officer
02/02/2023
Buy
$1.81
50,000
$91K
50,000
NASDAQ
TCRX
TScan Therapeutics
Silver Brian M.
/
officer: Chief Financial Officer
12/28/2022
Buy
$1.56
3,158
$5K
32,885
NASDAQ
TCRX
TScan Therapeutics
Silver Brian M.
/
officer: Chief Financial Officer
12/27/2022
Buy
$1.50
2,842
$4K
29,727
NASDAQ
TCRX
TScan Therapeutics
SOUTHWELL DAVID P
/
director, officer: Chief Executive Officer
07/25/2022
Buy
$3.27
100,000
$327K
100,000
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
06/01/2022
Buy
$3.17
9,146
$29K
9,146
NASDAQ
TCRX
TScan Therapeutics
Dorton Katina
/
director
06/01/2022
Buy
$3.17
9,146
$29K
9,146
NASDAQ
TCRX
TScan Therapeutics
SOUTHWELL DAVID P
/
director, officer: Chief Executive Officer
05/18/2022
Buy
$3.55
10,000
$35K
171,569
NASDAQ
TCRX
TScan Therapeutics
SOUTHWELL DAVID P
/
officer: Chief Executive Officer
05/18/2022
Buy
$3.62
15,000
$54K
161,569
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/11/2022
Buy
$1.99
22,983
$46K
2.53M
NASDAQ
TCRX
TScan Therapeutics
Baker Brothers Life Sciences LP
/
director:
05/10/2022
Buy
$1.99
22,983
$46K
2.53M
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/10/2022
Buy
$1.95
758,094
$1.478M
2.51M
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/10/2022
Buy
$1.93
101,831
$197K
1.75M
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/10/2022
Buy
$1.70
325,373
$553K
1.65M
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/11/2022
Buy
$1.99
2,882
$6K
256,209
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/10/2022
Buy
$1.95
95,060
$185K
253,327
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/10/2022
Buy
$1.93
12,769
$25K
158,267
NASDAQ
TCRX
TScan Therapeutics
BAKER BROS. ADVISORS LP
/
director, 10 percent owner:
05/10/2022
Buy
$1.70
40,800
$69K
145,498
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science Stock News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2024
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On Twitter
Advertise Your Company
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily Life Science Stock News
Register
or
Login
to Access Entire Platform.